Teva to pay New York $500M for role in opioid crisis - POLITICO
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva reaches $523 million deal to settle opioid lawsuit with New York | CNN Business
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Pharmaceuticals Found Liable in Landmark Opioid Trial - The New York Times
Teva proposes settlement in US opioid lawsuits | Israel National News - Arutz Sheva
Teva settles shareholder lawsuit over generic drug pricing for $420 mln | Reuters
Teva at the center of a lawsuit for raising drug prices - The Jerusalem Post
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva Pharmaceutical: Investment Opportunity During Fed Rate Hike (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva found liable for fueling opioid addiction in New York | Mint
Drugmaker Teva reaches opioid settlements worth $4.3 billion involving multiple states | Health News Florida
Teva to Pay $420M to Settle Shareholders' Generic Drug Pricing Lawsuit — Report
Teva lied about opioid role, New York says | Reuters
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Attorney General Morrisey sues opioid makers Johnson & Johnson, Teva Pharmaceuticals | WBOY.com
Teva settles shareholder lawsuit over generic drug | Business Insurance
Teva Pharmaceutical says it will defend claims it was involved in price-fixing in the US
Report: Teva settles investor lawsuit for $420M - www.israelhayom.com
Teva and 3 Drug Distributors Settle Opioid Lawsuits in Ohio Ahead of Trial | BioSpace
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
